Infectious Agent-Induced Rhinitis

  • S. Criscione
  • E. Porro
Part of the Respiratory Pharmacology and Pharmacotherapy book series (RPP)


Little is known about the epidemiology of nonallergic infectious agent-induced rhinitis. This is not completely surprising, as the diagnosis of infectious rhinitis relies on the recognition of signs and symptoms of varying severity, while a doubt about allergic underlying conditions is always present. In a recent study [1] the estimated minimum prevalence of rhinitis in the general population was 24%, of these, 3% had seasonal symptoms only (of whom 78% were atopic), 13 had perennial symptoms only (of whom 50% were atopic) and 8% had perennial symptoms with seasonal exacerbations (of whom 68% were atopic).


Respiratory Syncytial Virus Allergic Rhinitis Allergic Rhinitis Allergy Clin Immunol Common Cold 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Sibbald B, Ring E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 1991; 46: 895–901.PubMedCrossRefGoogle Scholar
  2. 2.
    Sibbald B. Epidemiology of allergic rhinitis. In: Burr ML, editor. Epidemiology of clinical allergy. Monographs in allergy. Basel: Karger, 1993: 61–79.Google Scholar
  3. 3.
    Calhoun WJ, Swenson CA, Dick EC, Schwartz LB, Lemanske RF Jr, Busse WW. Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 1991; 144: 1267–73.PubMedGoogle Scholar
  4. 4.
    Akerlund A, Greiff L, Andersson M, Bende M, Alkner U, Persson CG. Mucosal exudation of fibrinogen in coronavirus-induced common colds. Acta Otolaryngol 1993; 113: 642–48.PubMedCrossRefGoogle Scholar
  5. 5.
    Doyle WJ, Skoner DP, Seroky JT, Fireman P, Gwaltney JM. Effect of experimental rhinovirus 39 infection on the nasal response to histamine and cold air challenges in allergic and nonallergic subjects. J Allergy Clin Immunol 1994; 93: 534–42.PubMedCrossRefGoogle Scholar
  6. 6.
    Linden M, Greiff L, Andersson M, Svensson C, Akerlund A, Bende M, et al. Nasal cytokines in common cold and allergic rhinitis. Clin Exp Allergy 1995; 25: 166–72.PubMedCrossRefGoogle Scholar
  7. 7.
    Akerlund A, Bende M, Murphy C. Olfactory threshold and nasal mucosal changes in experimentally induced common cold. Acta Otolaryngol 1995; 115: 88–92.PubMedCrossRefGoogle Scholar
  8. 8.
    Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 1994; 94: 2200–2208.PubMedCrossRefGoogle Scholar
  9. 9.
    International Consensus Report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group. Allergy 1994; 49 (19 suppl): 1–34.Google Scholar
  10. 10.
    Silvers WS. The skier’s nose: a model of cold-induced rhinorrhea. Ann Allergy 1991; 67: 32–63.PubMedGoogle Scholar
  11. 11.
    Gerth van Wijk R, Dieges PH. Nasal hyper-responsiveness to histamine, methacholine and phentolamine in patients with perennial non-allergic rhinitis and in patients with infectious rhinitis. Clin Otolaryngol 1991; 16: 133–37.PubMedCrossRefGoogle Scholar
  12. 12.
    Corbo GM, Foresi A, Bonfitto P, Mugnano A, Agabiti N, Cole PJ. Measurement of nasal mucociliary clearance. Arch Dis Child 1989; 64: 546–50.PubMedCrossRefGoogle Scholar
  13. 13.
    Gwaltney JM, Scheld M, Sande MA, Sydnor A. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol 1992; 90: 457–62.PubMedCrossRefGoogle Scholar
  14. 14.
    Gittelman PD, Jacobs JB, Lebowitz AS, Tierno PM Jr. Staphylococcus aureus nasal carriage in patients with rhinosinusitis. Laryngoscope 1991; 101: 733–73.PubMedCrossRefGoogle Scholar
  15. 15.
    Yaniv E, Oppenheim D, Fuchs C. Chronic rhinitis in children. Int J Pediatr Otorhinolaryngol 1992; 23: 51–57.PubMedCrossRefGoogle Scholar
  16. 16.
    Porro E, Calamita P, Rana I, Montini L, Criscione S. Atopy and environmental factors in upper respiratory infections: an epidemiological survey on 2304 school children. Int J Pediatr Otorhinolaryngol 1992; 24: 111–20.PubMedCrossRefGoogle Scholar
  17. 17.
    Scheeren RA, Keehnen RM, Meijer CJ, van der Baan S. Defects in cellular immunity in chronic upper airway infections are associated with immunosuppressive retroviral pl5E- like proteins. Arch Otolaryngol Head Neck Surg 1993; 119: 439–43.PubMedGoogle Scholar
  18. 18.
    Kivity S, Schwarz Y, Fireman E. The association of perennial rhinitis with Trichophyton infection. Clin Exp Allergy 1992; 22: 498–500.PubMedCrossRefGoogle Scholar
  19. 19.
    Otten FW, Van Aarem A, Grote JJ. Long-term follow-up of chronic therapy resistant purulent rhinitis in Long-term follow-up of chronic therapy resistant purulent rhinitis in children. Clin Otolarnygol 1992; 17: 32–33.CrossRefGoogle Scholar
  20. 20.
    Roseler S, Holtappels G, Wagenmann M, Bachert C. Elevated levels of interleukins IL-1 beta, IL-6 and IL-8 in naturally acquired viral rhinitis. Eur Arch Otorhinolaryngol (suppl) 1995; 1: 61–63.CrossRefGoogle Scholar
  21. 21.
    Fryksmark U, Jannert M, Ohlsson K, Tegner H, Wihl JA. Secretory leukocyte protease inhibitor in normal, allergic and virus induced nasal secretions. Rhinology 1989; 27: 97–103.PubMedGoogle Scholar
  22. 22.
    Monto AS, Sullivan KM. Acute respiratory illness in the community: frequency of illness and the agent involved. Epidemiol Infect 1993; 110: 145–60.PubMedCrossRefGoogle Scholar
  23. 23.
    Wald ER, Guerra N, Beyers C. Upper respiratory tract infections in young children: duration of and frequency of complications. Pediatrics 1991; 87: 129–33.PubMedGoogle Scholar
  24. 24.
    Grigoriu D, Brambule J, Delacretaz J, Savary M. La sinusite maxillaire fungique. Dermatologica 1979; 159: 180–86.PubMedCrossRefGoogle Scholar
  25. 25.
    Laskownick AA, Kurdzielewicz J, Macura A, Okrasinkska-Cholewa B. Mycotic sinusitis in children. Mykosen 1978; 21: 407–11.Google Scholar
  26. 26.
    Stammberger H. Endoscopic surgery for mycotic and chronic recurring sinusitis. Ann Otol Rhinol Laryngol 1985; 94 (suppl 119): 1–11.Google Scholar
  27. 27.
    Blitzer A, Lawson W. Fungal infections of the nose and paranasal sinuses. Part 1. Otolaryngol Clin North Am 1993; 26: 1007–35.PubMedGoogle Scholar
  28. 28.
    Chakrabarti A, Sharma SC, Chander J. Epidemiology and pathogenesis of paranasal sinus mycoses. Otholaryngol Head Neck Surg 1992; 107: 745–50.Google Scholar
  29. 29.
    Milosev B, Margoub ES, Abdel A, Hassan AM. Primary aspergilloma of the paranasal sinus in the Sudan - a review of seventeen cases. Br J Surg 1969; 56: 132–37.PubMedCrossRefGoogle Scholar
  30. 30.
    Ence BK, Gourley DS, Jorgensen NL. Allergic fungal sinusitis. Am J Rhinol 1990; 4: 169–78.CrossRefGoogle Scholar
  31. 31.
    Zieske LA, Kopke RD, Hamill A. Dematiaceous fungal sinusitis. Otholaringol Head Neck Surg 1991; 105: 567–77.Google Scholar
  32. 32.
    Millar JW, Johnston A, Lamb D. Allergic aspergillosis of the maxillary sinuses. Thorax 1981; 36: 710.Google Scholar
  33. 33.
    Katzenstein AA, Sale SR, Greenberger PA. Allergic Aspergillus sinusitis: a newly recognized form of sinusitis. J Allergy Clin Immunol 1983; 72: 89–93.PubMedCrossRefGoogle Scholar
  34. 34.
    Tos M, Stangerup SE. Secretory otitis and pneumatization of the mastoid process: sexual differences in the size of mastoid cell system. Am J Otholaringol 1985; 6: 199–205.CrossRefGoogle Scholar
  35. 35.
    Battistini A, Grzincich GL. L’ipertrofia adenotonsillare. Rivista Italiana di Pediatria 1979; 5: 561–68.Google Scholar
  36. 36.
    Umeki S. Primary mucociliary transport failure. Respiration 1988; 54: 220–25.PubMedCrossRefGoogle Scholar
  37. 37.
    Young D. Surgical treatment of male interfertility. J Reprod Fertil 1970; 23: 541–42.PubMedCrossRefGoogle Scholar
  38. 38.
    Carson JL, Collier AM, Hu SS. Acquired ciliary defects in nasal epithelium of children with acute viral upper respiratory infections. N Engl J Med 1985; 312: 463–67.PubMedCrossRefGoogle Scholar
  39. 39.
    Taylor B, Norman AP, Orgel HA, Stokes CR, Turner MW, Soothill JF. Transient IgA deficiency and pathogenesis of infantile atopy. Lancet 1973; 3: 2–6.Google Scholar
  40. 40.
    Hinriksdottir I, Melen I. Allergic rhinitis and upper respiratory tract infections. Acta Otolaryngol Suppl 1994; 515: 30–32.PubMedCrossRefGoogle Scholar
  41. 41.
    Wright AL, Holberg CJ, Martinez FD, Halonen M, Morgan W, Taussig LM. Epidem iology of physician-diagnosed allergic rhinitis in childhood. Pediatrics 1994; 94: 895–901.PubMedGoogle Scholar
  42. 42.
    Bock SA. Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics 1987; 79: 683–88.PubMedGoogle Scholar
  43. 43.
    Kramer MS, Moroz BL. Do breastfeeding and delayed introduction of solid foods protect against subsequent atopic eczema? J Pediat 1981; 98: 546–50.PubMedCrossRefGoogle Scholar
  44. 44.
    Wright AL, Holberg CJ, Martinez FD. Breastfeeding and lower respiratory tract illness in the first year of life. Br Med J 1989; 299: 946–49.CrossRefGoogle Scholar
  45. 45.
    Holberg CJ, O’Rourke MK, Lebowitz MD. Multivariate analysis of ambient environmental factors and respiratory effects. Int J Epidemiol 1987; 16: 399–410.PubMedCrossRefGoogle Scholar
  46. 46.
    National Research Council, Environmental tobacco smoke: measuring exposure and assessing health effects. Washington, DC: National Academy Press 1989: 188–212.Google Scholar
  47. 47.
    Eggleston PA. Upper airway inflammatory diseases and bronchial hyperresponsiveness. J Allergy Clin Immunol 1988; 81: 1036–41.PubMedCrossRefGoogle Scholar
  48. 48.
    Korppi M. Viruses and airborne allergens as precipitants of obstructive respiratory difficulties in children. Ann Clin Res 1988; 20: 417–22.PubMedGoogle Scholar
  49. 49.
    Martinez FD, Taussig LM, Morgan WJ. Infants with upper respiratory illnesses have significant reductions in maximal expiratory flow. Pediatr Pulmonol 1990; 9: 91–95.PubMedCrossRefGoogle Scholar
  50. 50.
    Duff AL, Pomeranz ES, Gelber LE, Price GW, Farris H, Hyden FG, et al. Risk factors for acute wheezing in infant and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Pediatrics 1993; 92: 535–40.PubMedGoogle Scholar
  51. 51.
    Johnston S, Pattemore P, South S. Viral infections in exacerbations in schoolchildren with cough or wheeze: a longitudinal study. Am Rev Respir Dis 1992; 145: A546.Google Scholar
  52. 52.
    Johnston S, Bardin PG, Pattemore PK. Viruses as precipitants of asthma symptoms III: rhinoviruses: molecular biology and prospects for future intervention. Clin Exp Allergy 1993; 23: 237–46.PubMedCrossRefGoogle Scholar
  53. 53.
    Etzel R, Pattishall E, Haley N, Fletcher RH, Henderson F. Passive smoking and middle ear effusion among children in day care. Pediatrics 1992; 90: 228–32.PubMedGoogle Scholar
  54. 54.
    Doyle WJ, Skoner DP, Fireman P, Seroky JT, Green I, Ruben F, et al. Rhinovirus 39 infection in allergic and nonallergic subject. J Allergy Clin Immunol 1992; 89: 968–78.PubMedCrossRefGoogle Scholar
  55. 55.
    Gadomski AM, Rubin JD. Cough and cold medicine use in young children: a survey of Maryland pediatricians. Maryland Med J 1993; 42: 647–50.Google Scholar
  56. 56.
    Smith MBH, Feldman W. Over-the-counter cold medications: a critical review of clinical trials between 1950 and 1991. J Am Med Assoc 1993; 269: 2258–63.CrossRefGoogle Scholar
  57. 57.
    Jaffe G, Grimshaw JJ. Randomized single-blind trial in general practice comparing the efficacy and palatability of two cough Linctus preparations, “Pholcolix” and “Actifed” compound, in children with acute cough. Curr Med Res Opin 1983; 8: 594–99.PubMedCrossRefGoogle Scholar
  58. 58.
    Taylor JA, Novack AH, Almquist JR, Roger JE. Efficacy of cough suppressants in children. J Pediatr 1993; 122: 799–802.PubMedCrossRefGoogle Scholar
  59. 59.
    Middleton DB. An approach to pediatric upper respiratory infections. Am Fam Physician 1991; 44 (5 suppl): 33–40.Google Scholar
  60. 60.
    Gadomski AM. Potential interventions for preventing pneumonia among young children: lack of effect on antibiotic treatment for upper respiratory infections. Pediatr Infect Dis J 1993; 12: 115–20.PubMedCrossRefGoogle Scholar
  61. 61.
    Dolovich J, Mukherjee J, Salvatori VA. Intranasal ipratropium bromide to control the hypersecretion of vasomotor rhinitis: a dose response study. Am J Rhinol 1989; 3: 221–24.CrossRefGoogle Scholar
  62. 62.
    Dockhorn R, Grossman J, Posner M, Zinny M, Tinkelman D. A double-blind, placebo-controlled study of the safety and efficacy of ipratropium bromide nasal spray versus placebo in patients with common cold. J Allergy Clin Immunol 1992; 90: 1076–82.PubMedCrossRefGoogle Scholar
  63. 63.
    Forstall GJ, Macknin ML, Yen-Lieberman BR, Medendorp SV Effect of inhaling heated vapor on symptoms of the common cold. J Am Med Assoc 1994; 271: 1109–11.CrossRefGoogle Scholar
  64. 64.
    Hendley JO, Abbott RD, Beasley PP, Gwaltney JM. Effect of inhalation of hot humidified air on experimental rhinovirus infection. J Am Med Assoc 1994; 271: 1112–14.CrossRefGoogle Scholar
  65. 65.
    Smolensky MH, Reinberg A, Labrecque G. Twenty-four hour pattern in symptom intensity of viral and allergic rhinitis: treatment implications. J Allergy Clin Immunol 1995; 95: 1084–96.PubMedCrossRefGoogle Scholar
  66. 66.
    Collet JP, Decruet T, Kramer MS, Haggerty J, Floret D, Chomel JJ, et al. Stimulation of non-specific immunity to reduce the risk of recurrent infections in children attending day-care centers. Pediat Infect Dis J 1993; 12: 648–52.CrossRefGoogle Scholar
  67. 67.
    Meltzer EO, Tyrell RJ Jr, Rich D, Wood CC. A pharmacologic continuum in the treatment of rhinorrhea: the clinician as economist. J Allergy Clin Immunol 1995; 95: 1147–52.PubMedCrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 1997

Authors and Affiliations

  • S. Criscione
    • 1
  • E. Porro
    • 1
  1. 1.Department of Experimental MedicineUniversity of AquilaAquilaItaly

Personalised recommendations